Alexis Ogdie

Alexis Ogdie

UNVERIFIED PROFILE

Are you Alexis Ogdie?   Register this Author

Register author
Alexis Ogdie

Alexis Ogdie

Publications by authors named "Alexis Ogdie"

Are you Alexis Ogdie?   Register this Author

100Publications

3462Reads

17Profile Views

Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID).

J Rheumatol 2019 Oct 1. Epub 2019 Oct 1.

From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190219DOI Listing
October 2019

Comparative persistence on methotrexate and TNF inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

J Rheumatol 2019 Sep 1. Epub 2019 Sep 1.

From the University of Pennsylvania, Division of Rheumatology; Philadelphia Veterans Affairs Medical Center, Division of Rheumatology; University of Pennsylvania, Perelman School of Medicine, Department of Biostatistics Epidemiology and Informatics. Sources of support: This worked was supported by the McCabe Foundation; the Rheumatology Research Foundation Scientist Development Award to MG; the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [grant numbers K23 AR073931-01 to MG and R01 AR072363 to AO]; and the United States Veterans Affairs Clinical Science Research & Development [grant number I01 CX001703 to JB]. Michael George: research grant from Bristol-Myers Squibb, consulting fees from AbbVie (<$10,000) Joshua Baker: consulting fees from Bristol-Myers Squibb and Corrona (<$10,000 each). Alexis Ogdie: consulting fees from Abbvie, Amgen, BMS, Celgene, Corrona, Lilly, Novartis, Pfizer, Takeda (<$10,000 each) and research grant funding to the University of Pennsylvania from Novartis and Pfizer. Address correspondence to Michael D. George, 5 White Building, 3400 Spruce St, Philadelphia, PA 19104. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190299DOI Listing
September 2019

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

J Rheumatol 2019 Aug 15;46(8):990-995. Epub 2018 Dec 15.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Division of Immunology, Stanford University, Palo Alto, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co., Indianapolis, Indiana; University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, Bath; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Sorbonne Université; Rheumatology Department, Pitié Salpêtrière Hospital, AP-HP, Paris, France; VU Medical Centre, Amsterdam, the Netherlands; Global Medical Affairs, Pfizer Inc., Montreal, Quebec; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute for Health Policy Management and Evaluation, University of Toronto; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571063PMC
August 2019

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.

J Rheumatol 2019 Aug 15;46(8):996-1005. Epub 2019 Feb 15.

From the Division of Rheumatology, Department of Medicine, and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Amgen Inc., Thousand Oaks, California; Swedish-Providence-St. John's Health Systems and University of Washington, Seattle, Washington; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore; University of Leeds, Leeds; University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases; University of Bath, Bath, UK; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital; Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto; Department of Medicine, University of Toronto, Women's College Hospital; Department of Medicine, University of Toronto, Toronto Western Hospital, Toronto; Cochrane Musculoskeletal Group, Ottawa Hospital Research Institute, Centre for Practice-Changing Research; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario; Pfizer Inc., Montreal, Quebec, Canada; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Department of Medical Humanities, Patient Research Partner, Amsterdam University Medical Centre, Amsterdam, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Ireland; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181089DOI Listing
August 2019

Reliability and Validity of Patient-Reported Outcomes Measurement Information System Short Forms in Ankylosing Spondylitis.

J Rheumatol 2019 Aug 1. Epub 2019 Aug 1.

Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, John P. and Kathrine G. McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, TX; Division of Rheumatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. This project was supported by the National Institute of Health PO1- AR052915. The project has not received financial support from any commercial interests. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda and has received grants to the University of Pennsylvania from Pfizer and Novartis. JDR has served as a consultant for Janssen, Lilly, Novartis and Pfizer. AO is supported by K23 AR063764, R01 AR072363 and the Rheumatology Research Foundation. JDR is supported by the Spondyloarthritis Association of America. Address correspondence to Mark C. Hwang, M.D. John P. and Kathrine G. McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, TX. - 6431 Fannin MSB.5276, Houston, TX 77030. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190201DOI Listing
August 2019

SEAM-PsA: Seems Like Methotrexate Works in Psoriatic Arthritis?

Arthritis Rheumatol 2019 Jul;71(7):1027-1029

University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40872DOI Listing
July 2019

Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.

JAMA Dermatol 2019 Jun;155(6):700-707

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2019.0001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563547PMC
June 2019

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2019 Jun;95:11-19

From the Rheumatology Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Swedish Medical Center/Providence-St. Joseph Health, Seattle, Washington; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Department of Medical Humanities, Amsterdam University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190118DOI Listing
June 2019

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.

J Rheumatol Suppl 2019 Jun;95:33-37

From the Duke-NUS Medical School, Singapore; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah; Kezar Life Sciences, San Francisco; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam, the Netherlands; Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190122DOI Listing
June 2019

Measuring Psoriatic Arthritis Symptoms, A Core Domain in Psoriasis Clinical Trials.

J Am Acad Dermatol 2019 Jun 1. Epub 2019 Jun 1.

Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.05.075DOI Listing
June 2019

Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.

J Rheumatol 2019 May 15;46(5):475-482. Epub 2019 Jan 15.

From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.171034
Publisher Site
http://dx.doi.org/10.3899/jrheum.171034DOI Listing
May 2019

Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.

Nat Rev Rheumatol 2019 Mar;15(3):153-166

Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41584-019-0175-0DOI Listing
March 2019

Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.

J Pediatric Infect Dis Soc 2018 Dec;7(4):283-289

Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jpids/pix052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276024PMC
December 2018

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.

Eur Heart J 2018 10;39(39):3608-3614

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, South Tower, 7th Floor, 3400 Civic Center Blvd, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehx145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186275PMC
October 2018

Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.

Curr Rheumatol Rep 2018 10 26;20(12):76. Epub 2018 Oct 26.

Department of Medicine, Division of Rheumatology, New York University Langone Health, New York, NY, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11926-018-0785-6
Publisher Site
http://dx.doi.org/10.1007/s11926-018-0785-6DOI Listing
October 2018

Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities.

J Psoriasis Psoriatic Arthritis 2018 Oct 18;3(4):131-136. Epub 2018 Sep 18.

Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2475530318799072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660180PMC
October 2018

Classification and Outcome Measures for Psoriatic Arthritis.

Front Med (Lausanne) 2018 6;5:246. Epub 2018 Sep 6.

Division of Rheumatology and Krembil Research Institute, University Health Network, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2018.00246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135872PMC
September 2018

Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom.

J Invest Dermatol 2018 08 2;138(8):1726-1735. Epub 2018 Mar 2.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Epidemiology Biostatistics and Informatics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.01.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083876PMC
August 2018

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.

J Rheumatol Suppl 2018 Jun;94:17-25

From the Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Royal National Hospital for Rheumatic Diseases, Bath, UK; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; University of Oxford, Oxford, UK; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA; Department of Rheumatology, St. Vincents University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; VU Medical Centre, Amsterdam, the Netherlands; IQVIA, Duke University School of Medicine, Durham, North Carolina, USA; School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health, and Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180142DOI Listing
June 2018

GRAPPA 2017 Project Report.

J Rheumatol Suppl 2018 Jun;94:48-51

From the University of Utah, Salt Lake City, Utah; University of California at San Diego, La Jolla, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; New York University School of Medicine, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180139DOI Listing
June 2018

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2018 Jun;94:54-61

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Our Lady's Hospice and Care Services; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180141DOI Listing
June 2018

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies.

Ann Rheum Dis 2018 05 26;77(5):e23. Epub 2017 Jul 26.

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-212004DOI Listing
May 2018

Evaluation of Self-reported Patient Experiences: Insights from Digital Patient Communities in Psoriatic Arthritis.

J Rheumatol 2018 05 15;45(5):638-647. Epub 2018 Feb 15.

From The University of Texas Medical Branch, Galveston, Texas; Real Life Sciences Inc., New York; CreakyJoints, Global Healthy Living Foundation, Upper Nyack, New York; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA; Kinapse Ltd., London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170500DOI Listing
May 2018

Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.

J Invest Dermatol 2018 04 2;138(4):760-767. Epub 2017 Nov 2.

Department of Dermatology, Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X173309
Publisher Site
http://dx.doi.org/10.1016/j.jid.2017.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287638PMC
April 2018

Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.

Clin Rheumatol 2018 Feb 9;37(2):467-474. Epub 2017 Oct 9.

Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco VA Medical Center, 4150 Clement St,, Mailstop 111R, San Francisco, CA, 94121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3860-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908810PMC
February 2018

Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.

Ann Rheum Dis 2018 Jan 4;77(1):119-123. Epub 2017 Nov 4.

Department of Medicine, Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978759PMC
January 2018

The 2017 National Psoriasis Foundation Research Symposium.

J Psoriasis Psoriatic Arthritis 2018 Jan 8;3(1):15-17. Epub 2018 Mar 8.

University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2475530317753854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944357PMC
January 2018

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

J Rheumatol 2017 Oct 1;44(10):1522-1528. Epub 2017 Feb 1.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, University of Utah, Salt Lake City, Utah; Quintiles, Duke University School of Medicine, Durham, North Carolina; Division of Immunology, Stanford University, Palo Alto, California; Cleveland Clinic, Cleveland, Ohio; University of Pennsylvania, Philadelphia, Pennsylvania, USA; VU Medical Centre, Amsterdam; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Royal National Hospital for Rheumatic Diseases; Royal National Hospital for Rheumatic Diseases, Bath; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals UK National Health Service (NHS) Trust, Leeds, UK; Toronto Western Hospital; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto; Ottawa Hospital Research Institute, School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.160904
Publisher Site
http://dx.doi.org/10.3899/jrheum.160904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538953PMC
October 2017

The preclinical phase of PsA: a challenge for the epidemiologist.

Authors:
Alexis Ogdie

Ann Rheum Dis 2017 09 8;76(9):1481-1483. Epub 2017 Mar 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554090PMC
September 2017

Tumor necrosis factor inhibitors in psoriatic arthritis.

Expert Rev Clin Pharmacol 2017 Aug 22;10(8):899-910. Epub 2017 May 22.

a Department of Pharmacology and Experimental Therapeutics , Thomas Jefferson University , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1329009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348387PMC
August 2017

Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.

Rheumatology (Oxford) 2017 06;56(6):907-911

Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075466PMC
June 2017

The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Ann Rheum Dis 2017 May 16;76(5):882-885. Epub 2017 Jan 16.

Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://ard.bmj.com/content/early/2017/01/16/annrheumdis-2016
Web Search
http://dx.doi.org/10.1136/annrheumdis-2016-210441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384863PMC
May 2017

Proceedings of the GRAPPA 2016 Retreat.

J Rheumatol 2017 05;44(5):668-673

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute; Division of Dermatology, Toronto Western Hospital, University of Toronto, Ontario; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Advisory Services, QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester; New York Medical College, Valhalla; Hofstra Northwell School of Medicine, New Hyde Park, New York, New York; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cleveland Clinic, Cleveland, Ohio; University of Utah, Salt Lake City, Utah; University of Southern California, Los Angeles; University of California at San Diego, San Diego, California, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Division of Rheumatology, University of Cagliari, Cagliari, Italy, Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Federal University of Paraná, Curitiba, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170141DOI Listing
May 2017

International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting.

J Rheumatol 2017 05;44(5):684-685

From the UK National Institute for Health Research (NIHR), Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; PsAZZ Support Group, Bath, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cleveland Clinic, Cleveland, Ohio; Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York; University of California at San Diego, San Diego, California, USA; Our Lady's Hospice and Care Services, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170144DOI Listing
May 2017

Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.

J Rheumatol 2017 05;44(5):693-694

From the Beth Israel Deaconess Medical Center, Harvard Medical School; Harvard T.H. Chan School of Public Health; Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; New York University School of Medicine, New York, New York, USA; Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170148DOI Listing
May 2017

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.

J Rheumatol 2017 05;44(5):697-700

From Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Utah, Salt Lake City, Utah; QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington; International Dermatology Outcome Measurers, West Granby, Connecticut; Cleveland Clinic, Cleveland, Ohio; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Johns Hopkins University School of Medicine; Psoriatic Arthritis Program, Johns Hopkins Arthritis Center, Baltimore, Maryland, USA; VU Medical Centre, Amsterdam, the Netherlands; University of Toronto; Krembil Research Institute; Psoriatic Disease Program, Toronto Western Hospital; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; UK National Institute for Health Research (NIHR), Leeds; Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Royal United Hospital; Royal United Hospital; Pharmacy and Pharmacology, University of Bath, UK; Newman Clinical Research Professor, St. Vincent's University Hospital and University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Internal Medicine, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605807PMC
May 2017

Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting.

J Rheumatol 2017 05;44(5):703-705

From Advisory Services, QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Cleveland Clinic, Cleveland, Ohio; International Dermatology Outcome Measurers, West Granby, Connecticut; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Our Lady's Hospice and Care Services, Dublin, Ireland; Royal United Hospital, Bath; UK National Institute for Health Research (NIHR), Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; Biomedical Laboratory Sciences Program, Oslo University Hospital, Oslo, Norway; Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.170152
Publisher Site
http://dx.doi.org/10.3899/jrheum.170152DOI Listing
May 2017

The Changing Face of Clinical Trials in Psoriatic Arthritis.

Curr Rheumatol Rep 2017 Apr;19(4):21

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11926-017-0642-z
Publisher Site
http://dx.doi.org/10.1007/s11926-017-0642-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502109PMC
April 2017

Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.

Ann Rheum Dis 2017 Mar 25;76(3):521-525. Epub 2016 Jul 25.

Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209334DOI Listing
March 2017

Psoriasis and comorbid diseases: Epidemiology.

J Am Acad Dermatol 2017 Mar;76(3):377-390

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2016.07.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731650PMC
March 2017

Psoriasis and comorbid diseases: Implications for management.

J Am Acad Dermatol 2017 Mar;76(3):393-403

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2016.07.065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839668PMC
March 2017

Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.

Arthritis Care Res (Hoboken) 2017 01 28;69(1):51-57. Epub 2016 Nov 28.

Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191972PMC
January 2017

Patient-Reported Outcomes in Psoriatic Arthritis.

Rheum Dis Clin North Am 2016 05 16;42(2):265-83. Epub 2016 Mar 16.

Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, White Building, Room 5024, 3400 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2016.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853652PMC
May 2016

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

J Rheumatol 2016 05;43(5):965-9

From the Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; VU Medical Centre, Amsterdam, The Netherlands, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Internal Medicine, Division of Rheumatology, Hacettepe University Ankara, Ankara, Turkey; Toronto Western Hospital, Toronto, Ontario, Canada; Royal National Hospital for Rheumatic Diseases, Bath, UK; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Quintiles, Duke University School of Medicine, Durham, North Carolina, USA; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Cleveland Clinic, Cleveland, Ohio, USA; University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Division of Immunology, Stanford University, Palo Alto, California, USA; University of Pennsylvania, Philadelphia, Pennsylvania, USA.A.M. Orbai, MD, MHS, Division of Rheumatology, Johns Hopkins University; P.J. Mease, MD, Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine; M. de Wit, PhD, Patient Research Partner, VU Medical Centre; U. Kalyoncu, MD, Division of Rheumatology, Johns Hopkins University and Department of Internal Medicine, Division of Rheumatology, Hacettepe University Ankara; W. Campbell, BEd LLB, Patient Research Partner, Toronto Western Hospital; W. Tillett, BSc, MB, ChB, PhD, MRCP, Royal National Hospital for Rheumatic Diseases; L. Eder, MD, PhD, Toronto We

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5235387PMC
May 2016

Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual Meeting.

J Rheumatol 2016 05;43(5):970-3

From the VU Medical Centre, Amsterdam, The Netherlands; Krembil Research Institute of Toronto Western Hospital, and the University of Toronto, and the Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Johns Hopkins Division of Rheumatology, Baltimore, Maryland, USA; St. Vincent's University Hospital, Dublin, Ireland; Cleveland Clinic, Cleveland, Ohio, USA; Royal National Hospital for Rheumatic Diseases, Bath, UK; Duke University School of Medicine, Durham, North Carolina, USA.M. de Wit, PhD, Patient Research Partner, VU Medical Centre, Amsterdam, The Netherlands; W. Campbell, BEd, LLB, Patient Research Partner, Toronto Western Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, University Health Network; J. James, Patient Research Partner; C.A. Lindsay, PharmD, Patient Research Partner; R. MacDonald, Patient Research Partner; A.R. Moverley, MB, BS, BSc, MRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; A. Ogdie, University of Pennsylvania; A.M. Orbai, MD, MHS, Johns Hopkins Division of Rheumatology; D. O'Sullivan, BE, Patient Research Partner; A. Parkinson, Patient Research Partner; I. Steinkoenig, BA, Patient Research Partner; W. Tillett, BSc, MB ChB, PhD, MRCP, Royal National Hospital for Rheumatic Diseases; N. Goel, MD, Patient Research Partner, Duke University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160117DOI Listing
May 2016

Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis.

Int J Clin Rheumtol 2015 Dec;10(6):451-459

Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/ijr.15.45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847747PMC
December 2015

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.

J Rheumatol 2015 Nov 1;42(11):2198-203. Epub 2015 May 1.

From the Royal National Hospital for Rheumatic Diseases, Bath, UK; Toronto Western Hospital; Psoriatic Arthritis Program, University Health Network, Toronto Western Research Institute, Toronto, Ontario, Canada; St. Vincent's University Hospital, Dublin, Ireland; Quintiles; Duke University School of Medicine; Durham, North Carolina, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Chapel Allerton Hospital, Leeds, UK; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6 (UPMC Univ Paris 6), Institut Pierre Louis d'Epidémiologie et de Santé Publique; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland; Division of Immunology/Rheumatology, Stanford University School of Medicine, Portola Valley, California, USA; University of Bath, Bath, UK; Swedish Medical Center, University of Washington, Seattle, Washington; Hospital of the University of Pennsylvania (HUP), Philadelphia, Pennsylvania, USA.W. Tillett, MB, ChB, BSc, MRCP, PhD, Research Fellow, Royal National Hospital for Rheumatic Diseases; L. Eder, MD, PhD, Postdoctoral Research Fellow, Toronto Western Hospital; M. de Wit, PhD, OMERACT Patient Research Partner, The Netherlands; D.D. Gladman, MD, FRCPC, Director, Psoriatic Arthritis Program, University Health Network, Senior Scientist, Toronto Western Research Institute; O. FitzGerald, MD, FRCPI, FRCP( UK), Consultant Rheumatologist and Newman Clinical Research Professor, St. Vincent's University Hospital; N. Goel, MD, OMERACT Patient Research Partner, Quintiles, and Duke University School of Medicine; W. Campbell, BEd, LLB, OMERACT Patient Research Partner; P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital; L. Gossec, MD, PhD, Sorbonne Universités, UPMC Univ Paris 6, Institut Pierre Louis d'Epidémiologie et de Sant

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141156DOI Listing
November 2015

The Epidemiology of Psoriatic Arthritis.

Rheum Dis Clin North Am 2015 Nov 11;41(4):545-68. Epub 2015 Sep 11.

Division of Rheumatology, Children's Hospital of Philadelphia, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 3535 Market Street, Room 1526, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2015.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610151PMC
November 2015

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.

Curr Rheumatol Rep 2015 Oct;17(10):64

Division of Rheumatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 5 White Room 5024, 3400 Spruce St., Philadelphia, PA, 19104, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-015-0540-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278907PMC
October 2015

Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3.

J Invest Dermatol 2015 Sep;135(9):2148-2150

Department of Dermatology, Department of Biostatistics and Epidemiology, and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennslyvania, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538986PMC
September 2015

Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.

BMC Musculoskelet Disord 2015 Sep 3;16:237. Epub 2015 Sep 3.

Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, White Building, Room 5024, 3400 Spruce St., Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-015-0700-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559905PMC
September 2015

Distinctions between diagnostic and classification criteria?

Arthritis Care Res (Hoboken) 2015 Jul;67(7):891-7

Toronto Western and Mount Sinai Hospitals, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/acr.22583
Publisher Site
http://dx.doi.org/10.1002/acr.22583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482786PMC
July 2015

Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.

BMC Musculoskelet Disord 2015 Apr 19;16:93. Epub 2015 Apr 19.

Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-015-0552-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404567PMC
April 2015

Recognizing and managing comorbidities in psoriatic arthritis.

Curr Opin Rheumatol 2015 Mar;27(2):118-26

aDivision of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania bHospital for Special Surgery, New York cRheumatologic and Immunologic Disease, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00002281-201503000-000
Publisher Site
http://dx.doi.org/10.1097/BOR.0000000000000152DOI Listing
March 2015

Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.

Ann Rheum Dis 2015 Feb 28;74(2):326-32. Epub 2014 Oct 28.

Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, Center for Dermatoepidemiology and Translation, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2014-205675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341911PMC
February 2015

Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.

J Rheumatol 2014 Nov;41(11):2315-22

From the University of Pennsylvania, Philadelphia, Pennsylvania; Hospital for Special Surgery, New York, New York, USA; Toronto Western Hospital, Toronto, Ontario, Canada; Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa, and Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Carmel Medical Center, Faculty of Medicine, Technion, Haifa, Israel; Rheumatology, VA Sacramento Medical Center; Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, UC Davis, Davis, California; Division of Rheumatology, New York University School of Medicine, New York, New York; and the Cleveland Clinic, Cleveland, Ohio, USA.A. Ogdie, MD, MSCE, University of Pennsylvania; S. Schwartzman, MD, Hospital for Special Surgery; L. Eder, MD, PhD, Toronto Western Hospital; A.B. Maharaj, MB, BS, HDipIntMed(SA), FCP(SA), Nelson R. Mandela School of Medicine, University of KwaZulu Natal and Academic Medical Center, University of Amsterdam; D. Zisman, MD, Carmel Medical Center, Faculty of Medicine, Technion; S.P. Raychaudhuri, MD, Rheumatology, VA Sacramento Medical Center; Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, UC Davis; S.M. Reddy, MD, Division of Rheumatology, New York University School of Medicine; E. Husni, MD, MPH, Cleveland Clinic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140882DOI Listing
November 2014

Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

Pharmacoepidemiol Drug Saf 2014 Sep 5;23(9):918-22. Epub 2014 Jul 5.

Perelman School of Medicine at the University of Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.3677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149813PMC
September 2014

Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.

Rheumatology (Oxford) 2014 Feb 31;53(2):346-52. Epub 2013 Oct 31.

Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, 650 Albany Street, Suite 201, Boston, MA 02118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894671PMC
February 2014

Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.

Ann Rheum Dis 2014 Jan 21;73(1):149-53. Epub 2012 Dec 21.

Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, , Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2012-202424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883139PMC
January 2014

Teaching about how doctors think: a longitudinal curriculum in cognitive bias and diagnostic error for residents.

BMJ Qual Saf 2013 Dec 16;22(12):1044-50. Epub 2013 Aug 16.

Division of Nephrology, Department of Medicine, Allegheny General Hospital, West Penn Allegheny Health System, , Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjqs-2013-001987DOI Listing
December 2013

A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study.

Am J Cardiovasc Dis 2013 1;3(4):273-8. Epub 2013 Nov 1.

Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health Bethesda, MD ; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health Bethesda, MD.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819587PMC
November 2013

Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.

J Rheumatol 2013 Aug;40(8):1438-41

Department of Dermatology, University of California Davis, Sacramento, California 95816, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130458DOI Listing
August 2013

Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease.

Leuk Lymphoma 2013 Jun 19;54(6):1235-41. Epub 2013 Feb 19.

Abramson Cancer Center, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.736982DOI Listing
June 2013

In reply to Kunimatsu and Yoshizawa.

Acad Med 2013 Apr;88(4):436

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACM.0b013e318285f2ceDOI Listing
April 2013

Prevalence and treatment patterns of psoriatic arthritis in the UK.

Rheumatology (Oxford) 2013 Mar 7;52(3):568-75. Epub 2012 Dec 7.

Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 8 Penn Tower, 1 Convention Ave, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/kes324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573270PMC
March 2013

Seen through their eyes: residents' reflections on the cognitive and contextual components of diagnostic errors in medicine.

Acad Med 2012 Oct;87(10):1361-7

Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACM.0b013e31826742c9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703642PMC
October 2012

Obesity and the risk of psoriatic arthritis: a population-based study.

Ann Rheum Dis 2012 Aug 14;71(8):1273-7. Epub 2012 May 14.

Department of Science, Education, and Innovation, Landspitali University Hospital, Fossvogur, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2012-201299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645859PMC
August 2012

Light and electron microscopic features of synovium in patients with psoriatic arthritis.

Ultrastruct Pathol 2012 Aug;36(4):207-18

Division of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/01913123.2011.651523DOI Listing
August 2012

Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Eur J Nucl Med Mol Imaging 2011 Oct 14;38(10):1939-55. Epub 2011 Jul 14.

Department of Radiology, School of Medicine, University of Pennsylvania, and Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-011-1863-4DOI Listing
October 2011

A roadmap for education to improve the quality of care in gout.

Curr Opin Rheumatol 2010 Mar;22(2):173-80

Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania 19014, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00002281-201003000-000
Publisher Site
http://dx.doi.org/10.1097/BOR.0b013e328335eee3DOI Listing
March 2010

Barriers and facilitators of colorectal cancer screening among Mid-Atlantic Latinos: focus group findings.

Ethn Dis 2006 ;16(1):255-61

Latin American Cancer Research Coalition, Lombardi Comprehensive Cancer Center, USA.

View Article

Download full-text PDF

Source
June 2006